May 16 News: Resveratrol, Myxo Ring, ALSYNC, AF Ablation, More

For the week ending May 16, 2014, we discuss the following top cardiology news from heartwire:

• Resveratrol Does Not Reduce CVD Risk, Prolong Life

• Myxo Ring Dispute: Tale of Two Studies Puts IRB in Hot Seat

• ALSYNC: LV Endocardial Pacing Could Help in CRT Nonresponse

• Bias Among EPs Who Refer AF Patients for Ablation

And also, in brief:

• FDA Review Finds No Increased Risk of MI With Dabigatran (Pradaxa)

• FDA Approves Vorapaxar (Zontivity) to Cut MI, Stroke Risk

© 2014  WebMD, LLC

Cite this: May 16 News: Resveratrol, Myxo Ring, ALSYNC, AF Ablation, More - Medscape - May 16, 2014.